Do your patients suffer from excessive yawning?
Objective: Yawning has been described in relation to drugs such as serotonin reuptake inhibitors, levodopa, dopamine agonists, MAO B inhibitor, morphine, methadone, buprenorphine, dextromethorphan, benzodiazepine, lidocaine, and flecaine. This is a report of two patients, on long-term escitalopram t...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2007
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23574
- Acceso en línea:
- https://doi.org/10.1111/j.1600-0447.2006.00856.x
https://repository.urosario.edu.co/handle/10336/23574
- Palabra clave:
- Escitalopram
Serotonin uptake inhibitor
Adult
Article
Case report
Clinical examination
Clinical feature
Daytime somnolence
Depression
Drug dose reduction
Excessive yawning
Female
Human
Long term care
Male
Priority journal
Sedation
Side effect
Treatment outcome
Yawning
Citalopram
Depressive disorder
Female
Humans
Middle aged
Serotonin uptake inhibitors
Yawning
Case reports
Citalopram
Drug effects
Yawning
second-generation
drug
Antidepressive agents
Dose-response relationship
- Rights
- License
- Abierto (Texto Completo)